Amylyx Pharmaceuticals, Inc. AMLX Short- term Investments
Short- term Investments at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s short- term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s short- term investments?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported short- term investments of $50.63M in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s short- term investments changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s short- term investments decreased by 64.9% year-over-year, from $144.3M to $50.63M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s short- term investments?
- Over 2 years (2023 to 2025), Amylyx Pharmaceuticals, Inc.'s short- term investments has grown at a -33.0% compound annual growth rate (CAGR), from $201.16M to $90.33M.